Author | Age (years) | ASA scale | Type of surgery | Intervention | Sample size (n) | Control | Sample size (n) | PND assessment |
---|---|---|---|---|---|---|---|---|
Rasmussen 2006 [32] |  ≥ 60 | - | Knee replacement | 60–70% xenon | 21 | Intravenous propofol (3–5 mg kg−1 h−1) | 18 | ISPOCD neuropsychological test battery |
Coburn 2007 [33] | 65–75 | I–III | Elective surgerya | 60% xenon | 18 | 5.2–5.5% desflurane anesthesia | 20 | Test for Attentional Performance |
Bronco 2010 [6] | 42–74 | I-II | Elective surgeryb | 60% xenon | 29 | 1.4% Sevoflurane | 30 | Short Orientation Memory Concentration Test |
Stuttmann 2010 [34] |  ≥ 18 | I-II | Elective surgeryc | 63% xenon | 31 | 0.6% isoflurane | 30 | Syndrome short test |
Cremer 2011 [35] | 65–75 | I-III | Elective surgeryd | 60% xenon | 19 | 1.1–1.4% Sevoflurane | 20 | Test of Attentional Performance |
Stoppe 2013 [36] | 48–81 | II–IV | Elective CABG surgery | 45–50% xenon | 15 | 1–1.4% Sevoflurane | 15 | Confusion Assessment Method |
47–86 | III-IV | Elective OPCAB surgery | 50–60% xenon | 21 | 1.1–1.4% Sevoflurane | 21 | Confusion Assessment Method | |
Coburn 2018 [9] |  ≥ 75 | I-III | Hip fracture surgery | 60% xenon | 124 | 1.1–1.4% Sevoflurane | 132 | Confusion Assessment Method |
Al tmimi 2020 [8] |  ≥ 65 | III-IV | On-pump cardiac surgery | 40–60% xenon | 96 | 1.1–1.4% Sevoflurane | 94 | Confusion Assessment Method |